Svenska Aerogel Holding AB (publ) publishes disclosure document in connection with rights issue of shares

In connection with the Rights Issue, the Company has prepared a Disclosure Document in accordance with article 1.4 db Regulation (EU) 2017/1129 of the European Parliament and of Counsil of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (the "Prospectus Regulation"). The Disclosure Document has been drafted in accordance with annex IX of the Prospectus Regulation.

Today, Svenska Aerogel announces that the Disclosure Document has been registered with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and made available on the Company's website, www.aerogel.se.

To provide a more comprehensive basis for decision-making ahead of the forthcoming Rights Issue, the Company has also prepared an information brochure (the "Information Brochure"). The Information Brochure is available on the Company's website, www.aerogel.se and on Penser by Carnegie's website, www.carnegie.se.

Preliminary Timetable for the Rights Issue

6 March 2025: Record date for participation in the Rights Issue
7 March 2025: Publication of Disclosure Document and Information Brochure
10 March - 24 March 2025: Subscription period
10 March - 19 March 2025: Trading in subscription rights
25 March 2025: Estimated date for publication of the outcome of the Rights Issue

Advisors

Svenska Aerogel has mandated Penser by Carnegie, Carnegie Investment Bank AB (publ) and Eversheds Sutherland Advokatbyrå AB as financial and legal advisors respectively in connection with the Rights Issue.

 For further information, please contact:

Tor Einar Norbakk, CEO. Telephone: +46 (0)70 616 08 67. E-mail: toreinar.norbakk@aerogel.se

About Svenska Aerogel Holding AB (publ)

Svenska Aerogel manufactures and commercializes the mesoporous material Quartzene®. Svenska Aerogel's business concept is to meet the market's need for new materials that are in line with global sustainability objectives. Quartzene® is flexible and can be tailored to different applications to add essential properties to an end product. The company's vision is to be the most valued business partner providing pioneering material solutions for a sustainable world.

Svenska Aerogel Holding AB is listed on Nasdaq First North Growth Market. Certified Adviser is FNCA.

Gävle, March 7, 2025

IMPORTANT INFORMATION

THIS PRESS RELEASE DOES NOT CONTAIN AND DOES NOT CONSTITUTE AN OFFER TO ACQUIRE, SUBSCRIBE OR OTHERWISE TRADE IN SHARES, SUBSCRIPTION RIGHTS, BTA, CONVERTIBLES OR OTHER SECURITIES IN SVENSKA AEROGEL. THE OFFER TO RELEVANT PERSONS REGARDING THE SUBSCRIPTION OF SHARES IN SVENSKA AEROGEL WILL ONLY BE MADE THROUGH THE INFORMATION DOCUMENT IN THE FORM PRESCRIBED BY REGULATION (EU) 2024/2809, APPENDIX IX, THAT SVENSKA AEROGEL WILL PUBLISH ON ITS WEBSITE BEFORE THE START OF THE SUBSCRIPTION PERIOD.

THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE DISCLOSED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS), AUSTRALIA, JAPAN, CANADA, HONG KONG, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OR PUBLICATION WOULD BE ILLEGAL OR REQUIRE REGISTRATION OR OTHER MEASURES THAN THOSE THAT FOLLOW FROM SWEDISH LAW. ACTIONS THAT VIOLATE THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS.

NO SHARES, SUBSCRIPTION RIGHTS, BTA, CONVERTIBLES OR OTHER SECURITIES HAVE BEEN REGISTERED, AND NO SHARES, SUBSCRIPTION RIGHTS, BTA, CONVERTIBLES OR OTHER SECURITIES WILL BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933 AS CURRENTLY AMENDED ("SECURITIES ACT") OR THE SECURITIES LEGISLATION OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES AND NO SHARES, SUBSCRIPTION RIGHTS, BTA, CONVERTIBLES OR OTHER SECURITIES MAY BE OFFERED, SOLD, OR OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, EXCEPT UNDER AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS UNDER THE SECURITIES ACT AND IN COMPLIANCE WITH THE SECURITIES LEGISLATION IN THE RELEVANT STATE OR ANY OTHER JURISDICTION OF THE UNITED STATES.

IN ALL EEA MEMBER STATES ("EEA"), OTHER THAN SWEDEN, DENMARK, FINLAND AND NORWAY, THIS PRESS RELEASE IS INTENDED FOR AND IS DIRECTED ONLY TO QUALIFIED INVESTORS IN THE RELEVANT MEMBER STATE AS DEFINED IN THE REGULATION (EU) 2017/1129 (TOGETHER WITH ASSOCIATED DELEGATED REGULATIONS AND IMPLEMENTING REGULATIONS, THE "PROSPECTUS REGULATION"), I.E. ONLY TO THOSE INVESTORS WHO CAN RECEIVE THE OFFER WITHOUT AN APPROVED PROSPECTUS IN SUCH EEA MEMBER STATE.

IN THE UNITED KINGDOM, THIS PRESS RELEASE IS DIRECTED AND COMMUNICATED ONLY TO PERSONS WHO ARE QUALIFIED INVESTORS AS DEFINED IN ARTICLE 2(E) OF THE PROSPECTUS REGULATION (AS INCORPORATED INTO DOMESTIC LAW IN THE UNITED KINGDOM) WHO ARE (I) PERSONS WHO FALL WITHIN THE DEFINITION OF "PROFESSIONAL INVESTORS" IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (AS AMENDED) ("THE REGULATION"), OR (II) PERSONS COVERED BY ARTICLE 49(2)(A) - (D) IN THE REGULATION, OR (III) PERSONS TO WHOM THE INFORMATION MAY OTHERWISE LAWFULLY BE COMMUNICATED (ALL SUCH PERSONS REFERRED TO IN (I), (II) AND (III) ABOVE ARE COLLECTIVELY REFERRED TO AS "RELEVANT PERSONS"). SECURITIES IN THE COMPANY ARE ONLY AVAILABLE TO, AND ANY INVITATION, OFFER OR AGREEMENT TO SUBSCRIBE, PURCHASE OR OTHERWISE ACQUIRE SUCH SECURITIES WILL ONLY BE PROCESSED IN RESPECT OF RELEVANT PERSONS. PERSONS WHO ARE NOT RELEVANT PERSONS SHOULD NOT ACT BASED ON OR RELY ON THE INFORMATION CONTAINED IN THIS PRESS RELEASE.

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVESTMENT RECOMMENDATION. THE PRICE AND VALUE OF SECURITIES AND ANY INCOME FROM THEM CAN GO DOWN AS WELL AS UP AND YOU COULD LOSE YOUR ENTIRE INVESTMENT. PAST PERFORMANCE IS NOT A GUIDE TO FUTURE PERFORMANCE. INFORMATION IN THIS ANNOUNCEMENT CANNOT BE RELIED UPON AS A GUIDE TO FUTURE PERFORMANCE.

FORWARD-LOOKING STATEMENTS

MATTERS DISCUSSED IN THIS PRESS RELEASE MAY CONTAIN FORWARD-LOOKING STATEMENTS. SUCH STATEMENTS ARE ALL STATEMENTS THAT ARE NOT HISTORICAL FACTS AND CONTAIN EXPRESSIONS SUCH AS "BELIEVES", "EXPECTS", "ANTICIPATES", "INTENDS", "ESTIMATES", "WILL", "MAY", "CONTINUES", "SHOULD" AND OTHER SIMILAR EXPRESSIONS. THE FORWARD-LOOKING STATEMENTS IN THIS PRESS RELEASE ARE BASED ON VARIOUS ASSUMPTIONS, WHICH IN SEVERAL CASES ARE BASED ON ADDITIONAL ASSUMPTIONS. ALTHOUGH SVENSKA AEROGEL BELIEVES THESE ASSUMPTIONS WERE REASONABLE WHEN MADE, SUCH FORWARD-LOOKING STATEMENTS ARE SUBJECT TO KNOWN AND UNKNOWN RISKS, UNCERTAINTIES, CONTINGENCIES AND OTHER MATERIAL FACTORS THAT ARE DIFFICULT OR IMPOSSIBLE TO PREDICT AND BEYOND ITS CONTROL. SUCH RISKS, UNCERTAINTIES, CONTINGENCIES AND MATERIAL FACTORS COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED OR IMPLIED IN THIS COMMUNICATION THROUGH THE FORWARD-LOOKING STATEMENTS. THE INFORMATION, PERCEPTIONS AND FORWARD-LOOKING STATEMENTS CONTAINED IN PRESS RELEASE SPEAK ONLY AS AT ITS DATE, AND ARE SUBJECT TO CHANGE WITHOUT NOTICE. SVENSKA AEROGEL UNDERTAKES NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHER CIRCUMSTANCES, EXCEPT FOR WHEN IT IS REQUIRED BY LAW OR OTHER REGULATIONS. ACCORDINGLY, INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON ANY OF THESE FORWARD-LOOKING STATEMENTS.

INFORMATION TO DISTRIBUTORS

SOLELY FOR THE PURPOSES OF THE PRODUCT GOVERNANCE REQUIREMENTS CONTAINED WITHIN: (A) EU DIRECTIVE 2014/65/EU ON MARKETS IN FINANCIAL INSTRUMENTS, AS AMENDED ("MIFID II"); (B) ARTICLES 9 AND 10 OF COMMISSION DELEGATED DIRECTIVE (EU) 2017/593 SUPPLEMENTING MIFID II; AND (C) LOCAL IMPLEMENTING MEASURES (TOGETHER, THE "MIFID II PRODUCT GOVERNANCE REQUIREMENTS"), AND DISCLAIMING ALL AND ANY LIABILITY, WHETHER ARISING IN TORT, CONTRACT OR OTHERWISE, WHICH ANY "MANUFACTURER" (FOR THE PURPOSES OF THE MIFID II PRODUCT GOVERNANCE REQUIREMENTS) MAY OTHERWISE HAVE WITH RESPECT THERETO, THE SHARES IN SVENSKA AEROGEL HAVE BEEN SUBJECT TO A PRODUCT APPROVAL PROCESS, WHICH HAS DETERMINED THAT SUCH SHARES ARE: (I) COMPATIBLE WITH AN END TARGET MARKET OF RETAIL INVESTORS AND INVESTORS WHO MEET THE CRITERIA OF PROFESSIONAL CLIENTS AND ELIGIBLE COUNTERPARTIES, EACH AS DEFINED IN MIFID II; AND (II) ELIGIBLE FOR DISTRIBUTION THROUGH ALL DISTRIBUTION CHANNELS AS ARE PERMITTED BY MIFID II (THE "TARGET MARKET ASSESSMENT"). NOTWITHSTANDING THE TARGET MARKET ASSESSMENT, DISTRIBUTORS SHOULD NOTE THAT: THE PRICE OF THE SHARES IN SVENSKA AEROGEL MAY DECLINE AND INVESTORS COULD LOSE ALL OR PART OF THEIR INVESTMENT; THE SHARES IN SVENSKA AEROGEL OFFER NO GUARANTEED INCOME AND NO CAPITAL PROTECTION; AND AN INVESTMENT IN THE SHARES IN SVENSKA AEROGEL IS COMPATIBLE ONLY WITH INVESTORS WHO DO NOT NEED A GUARANTEED INCOME OR CAPITAL PROTECTION, WHO (EITHER ALONE OR IN CONJUNCTION WITH AN APPROPRIATE FINANCIAL OR OTHER ADVISER) ARE CAPABLE OF EVALUATING THE MERITS AND RISKS OF SUCH AN INVESTMENT AND WHO HAVE SUFFICIENT RESOURCES TO BE ABLE TO BEAR ANY LOSSES THAT MAY RESULT THEREFROM. THE TARGET MARKET ASSESSMENT IS WITHOUT PREJUDICE TO THE REQUIREMENTS OF ANY CONTRACTUAL, LEGAL OR REGULATORY SELLING RESTRICTIONS IN RELATION TO THE RIGHTS ISSUE.

FOR THE AVOIDANCE OF DOUBT, THE TARGET MARKET ASSESSMENT DOES NOT CONSTITUTE: (A) AN ASSESSMENT OF SUITABILITY OR APPROPRIATENESS FOR THE PURPOSES OF MIFID II; OR (B) A RECOMMENDATION TO ANY INVESTOR OR GROUP OF INVESTORS TO INVEST IN, OR PURCHASE, OR TAKE ANY OTHER ACTION WHATSOEVER WITH RESPECT TO THE SHARES IN SVENSKA AEROGEL.

EACH DISTRIBUTOR IS RESPONSIBLE FOR UNDERTAKING ITS OWN TARGET MARKET ASSESSMENT IN RESPECT OF THE SHARES IN SVENSKA AEROGEL AND DETERMINING APPROPRIATE DISTRIBUTION CHANNELS.